Bausch + Lomb Co. (NYSE:BLCO – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday after ...

Stifel lowered the firm’s price target on Bausch + Lomb (BLCO) to $15 from $17 and keeps a Hold rating on the shares. Following last week’s ...

Wells Fargo & Company reiterated their equal weight rating on shares of Bausch + Lomb (NYSE:BLCO – Free Report) in a report issued on Friday morning, MarketBeat.com reports. They currently have a $15.

Here are some of the top stories moving markets midday Friday. The "Magnificent Seven" are part of the reason stocks are ...

Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...

Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...

Fintel reports that on March 28, 2025, Wells Fargo downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Overweight to ...

Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.

Investors looked ahead to the latest reading of the personal consumption expenditures price index, due on Friday.

These are provided as guidelines only and approval is not guaranteed. If you value simplicity, the Wells Fargo Active Cash offers just that with rewards that are straightforward to earn and redeem.

Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Reid covers the Consumer Cyclical sector, focusing on stocks such as Lennar, KB ...

Bausch + Lomb (BLCO) announced the U.S. launch of Arise ... Vance Thompson Vision, West Fargo, North Dakota. “The ease and precision of Arise will be a welcome addition to my practice.” ...